NCT04014374 Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab Status RECRUITING Phase N/A
NCT03932279 Characterization of the Microbiome in Cutaneous T Cell Lymphoma Status RECRUITING Phase N/A
NCT03775525 Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer Status UNKNOWN Phase PHASE1
NCT03602157 Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03385226 A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03292406 A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) Status COMPLETED Phase PHASE2
NCT03235869 Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma Status WITHDRAWN Phase EARLY_PHASE1
NCT02576496 Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT02546440 Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) Status COMPLETED Phase PHASE2
NCT02192021 Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) Status COMPLETED Phase PHASE1
NCT01676831 Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) Status COMPLETED Phase PHASE1/PHASE2
NCT01663571 STAT3 in T Cells: At The Crossroads of Inflammation and Cancer Status TERMINATED Phase N/A
NCT01569724 Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma Status COMPLETED Phase PHASE4
NCT01460914 Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment Status COMPLETED Phase N/A
NCT01198665 RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas Status COMPLETED Phase PHASE1/PHASE2
NCT01132989 Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT00221039 Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A Status COMPLETED Phase PHASE4
NCT00007345 Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma Status COMPLETED Phase PHASE2